This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting central nervous system (CNS) disorders, such as antidepressants or antipsychotics, due to its structural properties that can influence receptor binding and activity. Additionally, its trifluoro and methoxy groups make it valuable in medicinal chemistry for optimizing drug efficacy and metabolic stability. It may also be explored in the development of fluorinated analogs of existing drugs to enhance their pharmacokinetic profiles.